267 related articles for article (PubMed ID: 28620815)
1. Radiation-related toxicities and outcomes in endometrial cancer: are obese women at a disadvantage?
Smits A; McGrane J; Lopes A; Kent E; Bekkers R; Massuger L; Simpson N; Galaal K
Int J Clin Oncol; 2017 Oct; 22(5):945-953. PubMed ID: 28620815
[TBL] [Abstract][Full Text] [Related]
2. Radiation-Associated Toxicities in Obese Women with Endometrial Cancer: More Than Just BMI?
Dandapani SV; Zhang Y; Jennelle R; Lin YG
ScientificWorldJournal; 2015; 2015():483208. PubMed ID: 26146653
[TBL] [Abstract][Full Text] [Related]
3. Overuse of external beam radiotherapy for stage I endometrial cancer.
Wright JD; Margolis B; Hou JY; Burke WM; Tergas AI; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL
Am J Obstet Gynecol; 2016 Jul; 215(1):75.e1-7. PubMed ID: 26875941
[TBL] [Abstract][Full Text] [Related]
4. Assessing the Quality of Life in Patients With Endometrial Cancer Treated With Adjuvant Radiotherapy.
Karabuga H; Gultekin M; Tulunay G; Yuce K; Ayhan A; Yuce D; Yildiz F
Int J Gynecol Cancer; 2015 Oct; 25(8):1526-33. PubMed ID: 26207785
[TBL] [Abstract][Full Text] [Related]
5. Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients?
Nieto K; Martin B; Pham N; Palmere L; Silva SR; Winder A; Liotta M; Potkul RK; Small W; Harkenrider MM
Brachytherapy; 2018; 17(6):929-934. PubMed ID: 30227976
[TBL] [Abstract][Full Text] [Related]
6. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.
Kauffmann G; Wu T; Al-Hallaq H; Hasan Y
Brachytherapy; 2017; 16(1):141-146. PubMed ID: 27866953
[TBL] [Abstract][Full Text] [Related]
7. High-dose-rate interstitial brachytherapy for the treatment of high-volume locally recurrent endometrial carcinoma.
Huang K; D'Souza D; Patil N; Velker V; Leung E; Stitt L; Whiston F; Sugimoto A; McGee J; Prefontaine M
Brachytherapy; 2016; 15(5):543-8. PubMed ID: 27475479
[TBL] [Abstract][Full Text] [Related]
8. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant Chemotherapy and Vaginal Vault Brachytherapy With or Without Pelvic Radiotherapy for Stage 1 Papillary Serous or Clear Cell Endometrial Cancer.
Tétreault-Laflamme A; Nguyen-Huynh TV; Carrier JF; Samouëlian V; Sauthier P; Beauchemin MC; Barkati M
Int J Gynecol Cancer; 2016 Feb; 26(2):301-6. PubMed ID: 26745699
[TBL] [Abstract][Full Text] [Related]
10. Definitive radiation therapy for endometrial cancer in medically inoperable elderly patients.
Wegner RE; Beriwal S; Heron DE; Richard SD; Kelly JL; Edwards RP; Sukumvanich P; Zorn KK; Krivak TC
Brachytherapy; 2010; 9(3):260-5. PubMed ID: 20122872
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial.
de Boer SM; Nout RA; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Stenfert Kroese MC; Oerlemans S; Putter H; Verhoeven-Adema KW; Nijman HW; Creutzberg CL
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):797-809. PubMed ID: 26530748
[TBL] [Abstract][Full Text] [Related]
12. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial.
Nout RA; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Stenfert Kroese MC; van Bunningen BN; Smit VT; Nijman HW; van den Tol PP; Creutzberg CL
J Clin Oncol; 2009 Jul; 27(21):3547-56. PubMed ID: 19546404
[TBL] [Abstract][Full Text] [Related]
13. Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma.
Park HS; Ratner ES; Lucarelli L; Polizzi S; Higgins SA; Damast S
Brachytherapy; 2015; 14(4):464-70. PubMed ID: 25887343
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis.
Kong A; Johnson N; Kitchener HC; Lawrie TA
J Natl Cancer Inst; 2012 Nov; 104(21):1625-34. PubMed ID: 22962693
[TBL] [Abstract][Full Text] [Related]
15. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
16. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study.
von Gruenigen VE; Tian C; Frasure H; Waggoner S; Keys H; Barakat RR
Cancer; 2006 Dec; 107(12):2786-91. PubMed ID: 17096437
[TBL] [Abstract][Full Text] [Related]
17. The impact of BMI on quality of life in obese endometrial cancer survivors: does size matter?
Smits A; Lopes A; Das N; Bekkers R; Galaal K
Gynecol Oncol; 2014 Jan; 132(1):137-41. PubMed ID: 24262880
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiotherapy for endometrial cancer--a comparative review of radiotherapy technique with acute toxicity.
Koh YV; Tang JI; Choo BA; Koh MS; Lee KM
Eur J Gynaecol Oncol; 2014; 35(2):128-33. PubMed ID: 24772913
[TBL] [Abstract][Full Text] [Related]
19. Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer.
Bahng AY; Dagan A; Bruner DW; Lin LL
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):667-73. PubMed ID: 21300451
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate Rotte "Y" applicator brachytherapy for definitive treatment of medically inoperable endometrial cancer: 10-year results.
Coon D; Beriwal S; Heron DE; Kelley JL; Edwards RP; Sukumvanich P; Zorn KK; Krivak TC
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):779-83. PubMed ID: 18258388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
